Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...

The FDA has issued its first emergency use authorization for a COVID-19 molecular diagnostic test that does not require a prescription and can be used at home. Developed by Cue Health, the Cue ...

Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...

With fall around the corner, Ohio residents may have concerns about the COVID-19 virus and other respiratory illnesses. Pharmacies and other medical centers across the state are stocking up on their ...

Update: This program has ended and free tests are not current available from the government website. As cases of a new COVID-19 variant tick upward across the U.S., the federal government is again ...

Households across the country are now able to once again, order up to four COVID-19 test kits at no cost. On Thursday, Sept. 26, the Administration for Strategic Preparedness and Response, an agency ...

Add Yahoo as a preferred source to see more of our stories on Google. With fall around the corner, Ohio residents may have concerns about the COVID-19 virus and other respiratory illnesses. Pharmacies ...